Presbyopia Therapies, LLC
Funding rounds
3 counted as startup funding. Open the number of investors for the round's details.
How it makes money#
What its filings and its own website say, sentence by sentence, each with its source.
Presbyopia Therapies, LLC chose not to state its revenue in its newest notice of a funding round (Mar 2023).
SEC Form D · Mar 2023
The industry group it chose in its notices: Pharmaceuticals.
SEC Form D · Mar 2023
Products and services#
No products or services on record: no website is on record for it in an official source (its SEC filings, Wikidata).
Investors#
No investor of Presbyopia Therapies, LLC is named in an official source we use. Its funding notices give only how many investors bought, not who they are.
Executives and directors
As the company named them in its notices. Directors of a funded startup are often partners of its investors.
| Name | Role | Named in |
|---|---|---|
| Evert Schimmelpennink | Executive officer | Mar 2023 |
| Gerald W. Horn | Executive Officer and Director | Nov 2020 |
| James W. McCollum | Executive Officer and Director | Nov 2020 |
| Gerald Horn | MANAGER | Jun 2016 |
| JAMES McCOLLUM | MANAGER | Jun 2016 |
| Mark Lester | MANAGER | Jun 2016 |
| Chris Dimitropoulos | Director | Mar 2023 |
| Clare Ozawa | Director | Mar 2023 |
| Evert Schimmelpennink | Director | Mar 2023 |
| Frederic Guerard | Director | Mar 2023 |
| James McCollum | Director | Mar 2023 |
| Stefan Larson | Director | Mar 2023 |
| Zach Scheiner | Director | Mar 2023 |
| Fred Guerard | Director | Nov 2022 |
| Gerald W. Horn | Executive Officer and Director | Nov 2020 |
| James W. McCollum | Executive Officer and Director | Nov 2020 |
| Mark W. Lester | Director | Nov 2020 |